Header Logo

Connection

Douglas Corley to Diphosphonates

This is a "connection" page, showing publications Douglas Corley has written about Diphosphonates.
Connection Strength

0.891
  1. Oral health considerations in older women receiving oral bisphosphonate therapy. J Am Geriatr Soc. 2011 May; 59(5):916-22.
    View in: PubMed
    Score: 0.179
  2. Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure. Osteoporos Int. 2019 Dec; 30(12):2515-2520.
    View in: PubMed
    Score: 0.160
  3. Oral bisphosphonates and colorectal cancer. Sci Rep. 2017 03 10; 7:44177.
    View in: PubMed
    Score: 0.135
  4. The association of race/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy. Bone. 2016 Apr; 85:142-7.
    View in: PubMed
    Score: 0.124
  5. Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers. PLoS One. 2015; 10(10):e0140180.
    View in: PubMed
    Score: 0.122
  6. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg. 2010 Feb; 68(2):243-53.
    View in: PubMed
    Score: 0.080
  7. Clinical correlates of atypical femoral fracture. Bone. 2012 Jul; 51(1):181-4.
    View in: PubMed
    Score: 0.048
  8. Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years. BMC Musculoskelet Disord. 2020 Dec 03; 21(1):801.
    View in: PubMed
    Score: 0.044

© 2024 Kaiser Permanente